Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism

Abstract.  Caesar R, Fåk F, Bäckhed F (Department of Molecular and Clinical Medicine, Sahlgrenska Center for Cardiovascular and Metabolic Research/Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden). Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. (Review) J Intern Med 2010; 268: 320–328.

[1]  Z. Tonar,et al.  Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. , 2010, Journal of atherosclerosis and thrombosis.

[2]  J. Collins,et al.  Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. , 2010, Cell metabolism.

[3]  K. Imaizumi,et al.  Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial , 2010, European Journal of Clinical Nutrition.

[4]  Mark Hamer,et al.  Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey , 2010, BDJ.

[5]  F. Bäckhed,et al.  The gut microbiota modulates host energy and lipid metabolism in mice[S] , 2010, Journal of Lipid Research.

[6]  R. Ley,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2010, Science.

[7]  M. Kalliomäki,et al.  The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years , 2010, International Journal of Obesity.

[8]  F. Bäckhed,et al.  Coordinated regulation of the metabolome and lipidome at the host-microbial interface. , 2010, Biochimica et biophysica acta.

[9]  G. Musso,et al.  Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders , 2010, Current opinion in lipidology.

[10]  E. Zoetendal,et al.  The environment within: how gut microbiota may influence metabolism and body composition , 2010, Diabetologia.

[11]  Jeffrey N. Weiser,et al.  Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.

[12]  Ruth E Ley,et al.  Obesity and the human microbiome , 2010, Current opinion in gastroenterology.

[13]  G. Romito,et al.  Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. , 2009, Journal of medical microbiology.

[14]  Patrice D Cani,et al.  Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. , 2009, Current opinion in pharmacology.

[15]  A. Davies,et al.  Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis , 2009, Circulation.

[16]  I. Verma,et al.  Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. , 2009, Cell metabolism.

[17]  N. Borges,et al.  Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol , 2009, Journal of Dairy Research.

[18]  P. Turnbaugh,et al.  The core gut microbiome, energy balance and obesity , 2009, The Journal of physiology.

[19]  F. Bäckhed,et al.  Regulation of Serum Amyloid A3 (SAA3) in Mouse Colonic Epithelium and Adipose Tissue by the Intestinal Microbiota , 2009, PloS one.

[20]  Patrice D Cani,et al.  The role of the gut microbiota in energy metabolism and metabolic disease. , 2009, Current pharmaceutical design.

[21]  P. He,et al.  Chlamydia pneumoniae induces macrophage‐derived foam cell formation via PPAR α and PPAR γ‐dependent pathways , 2009, Cell biology international.

[22]  F. Bäckhed,et al.  Intestinal microbiota during infancy and its implications for obesity. , 2009, Journal of pediatric gastroenterology and nutrition.

[23]  T. van de Wiele,et al.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability , 2009, Gut.

[24]  M. Jaff,et al.  Anti-Chlamydial Antibiotic Therapy for Symptom Improvement in Peripheral Artery Disease: Prospective Evaluation of Rifalazil Effect on Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia pneumoniae Seropositive Patients (PROVIDENCE-1) , 2009, Circulation.

[25]  E. Rossi,et al.  Effects of probiotic bacteria, isoflavones and simvastatin on lipid profile and atherosclerosis in cholesterol-fed rabbits: a randomized double-blind study , 2009, Lipids in Health and Disease.

[26]  G. Hotamisligil,et al.  Nutrient sensing and inflammation in metabolic diseases , 2008, Nature Reviews Immunology.

[27]  Shuang Chen,et al.  Chlamydia pneumoniae-Induced Foam Cell Formation Requires MyD88-Dependent and -Independent Signaling and Is Reciprocally Modulated by Liver X Receptor Activation1 , 2008, The Journal of Immunology.

[28]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[29]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[30]  A. Tall,et al.  HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. , 2008, Cell metabolism.

[31]  J. Ruidavets,et al.  Energy intake is associated with endotoxemia in apparently healthy men. , 2008, The American journal of clinical nutrition.

[32]  C. Glass,et al.  A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways* , 2007, Journal of Biological Chemistry.

[33]  M. Karin,et al.  JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. , 2007, Cell metabolism.

[34]  D. Webb,et al.  A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. , 2007, The American journal of clinical nutrition.

[35]  C. Knauf,et al.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.

[36]  J. Carvalheira,et al.  Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance , 2007, Diabetes.

[37]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[38]  S Kumar,et al.  Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. , 2007, American journal of physiology. Endocrinology and metabolism.

[39]  P. Brun,et al.  Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[40]  Jeffrey I. Gordon,et al.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.

[41]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[42]  S. Yamaoka,et al.  Role of the Toll-like Receptor 4/NF-&kgr;B Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[43]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[44]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[45]  A. Marshak‐Rothstein.  Toll-like receptors in systemic autoimmune disease , 2006, Nature Reviews Immunology.

[46]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[47]  E. Rock,et al.  Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice , 2006, British Journal of Nutrition.

[48]  J. Alvarez‐Leite,et al.  Effect of Lactobacillus delbrueckii on cholesterol metabolism in germ-free mice and on atherogenesis in apolipoprotein E knock-out mice. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[49]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[50]  Alexander Reinecke,et al.  Detection of Diverse Bacterial Signatures in Atherosclerotic Lesions of Patients With Coronary Heart Disease , 2006, Circulation.

[51]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[52]  P. Tobias,et al.  Modulation of atherosclerosis in mice by Toll-like receptor 2. , 2005, The Journal of clinical investigation.

[53]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Berger,et al.  Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[55]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[56]  B. Cohen,et al.  C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.

[57]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[58]  A. Progulske-Fox,et al.  Human Atherosclerotic Plaque Contains Viable Invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[59]  Ryan T Demmer,et al.  Periodontal Microbiota and Carotid Intima-Media Thickness: The Oral Infections and Vascular Disease Epidemiology Study (INVEST) , 2005, Circulation.

[60]  A. Hevener,et al.  IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.

[61]  M. Pfeffer,et al.  C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.

[62]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  B. Riggs,et al.  A genetic basis for the “Adonis” phenotype of low adiposity and strong bones , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[65]  B. Beutler,et al.  Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.

[66]  F. C. Gibson,et al.  Innate Immune Recognition of Invasive Bacteria Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[67]  K. Moore,et al.  Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways , 2004, Nature Medicine.

[68]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[69]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[70]  J. Muhlestein.  Antibiotic treatment of atherosclerosis , 2003, Current opinion in lipidology.

[71]  G. Cheng,et al.  Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. , 2003, Molecular cell.

[72]  Jianping Ye,et al.  Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex* 210 , 2002, The Journal of Biological Chemistry.

[73]  M. Naruszewicz,et al.  Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. , 2002, The American journal of clinical nutrition.

[74]  D. Mangelsdorf,et al.  The liver X receptor gene team: Potential new players in atherosclerosis , 2002, Nature Medicine.

[75]  B. Maisch,et al.  Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. , 2002, The Journal of Periodontology.

[76]  D. Schwartz,et al.  Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.

[77]  M. Hornef,et al.  Toll-like Receptor 4 Resides in the Golgi Apparatus and Colocalizes with Internalized Lipopolysaccharide in Intestinal Epithelial Cells , 2002, The Journal of experimental medicine.

[78]  M. Trevisan,et al.  Identification of periodontal pathogens in atheromatous plaques. , 2000, Journal of periodontology.

[79]  M. Burnett,et al.  Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[80]  Y. Chao,et al.  Infectious Agents Are Not Necessary for Murine Atherogenesis , 2000, The Journal of experimental medicine.

[81]  Roger Davis,et al.  The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.

[82]  M. Médici,et al.  Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. , 2000, Journal of dairy science.

[83]  S. Kiechl,et al.  Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. , 1999, Journal of the American College of Cardiology.

[84]  Josef Niebauer,et al.  Endotoxin and immune activation in chronic heart failure: a prospective cohort study , 1999, The Lancet.

[85]  R. Berg,et al.  The indigenous gastrointestinal microflora. , 1996, Trends in microbiology.

[86]  I. Mattsby‐Baltzer,et al.  Endotoxin levels in sera of elderly individuals. , 1994, Clinical and diagnostic laboratory immunology.

[87]  M. Nieminen,et al.  Association between dental health and acute myocardial infarction. , 1989, BMJ.

[88]  C. Larkin,et al.  Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. , 1983, Laboratory animal science.

[89]  S. Sabesin,et al.  Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine. , 1977, Journal of lipid research.

[90]  Jian Zhong,et al.  Chylomicrons promote intestinal absorption of lipopolysaccharides , 2008 .

[91]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[92]  L. Bertók,et al.  Plasma endotoxin level of healthy donors. , 2002, Acta microbiologica et immunologica Hungarica.

[93]  M. Storck,et al.  Endotoxin release and endotoxin neutralizing capacity during colonoscopy. , 2001, Clinica chimica acta; international journal of clinical chemistry.